clinical trial · NCT05856370
The Ailliance Post-Market Clinical Study
Medtronic Spinal and Biologics·N/A·recruiting·n = 1,000
Spinal DeformitySpinal Degenerative DisorderSpinal Fusion FailureSpinal TraumaSpinal Tumor CaseFollow-up schedule: pre-operative baseline up to 24-months post-procedure
brief summary
The purpose of this clinical study is to collect performance and safety data for post-market Medtronic devices indicated for cranial and/or spinal indication(s). Subjects are enrolled and followed postoperatively to 24 months. The Ailliance clinical study is intended to collect data congruous with routine clinical care practices.
started
May 1, 2023
primary completion
May 1, 2031
completion
May 1, 2031
last updated
Jun 30, 2026
official title
The Ailliance Post-Market Clinical Study: All enablIng technoLogies, bioLogics, IDS, And Core spiNe produCt collEction
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol